{
    "2018-12-13": [
        [
            {
                "time": "2018-12-13",
                "original_text": "J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study",
                "features": {
                    "keywords": [
                        "Tremfya",
                        "Cosentyx",
                        "Head-to-Head",
                        "Study"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-13",
                "original_text": "Pre-Market Most Active for Dec 13, 2018: GE, LPL, KEP, NVS, ERIC, SQQQ, QD, PKX, AMD, MRNS, QQQ, TQQQ",
                "features": {
                    "keywords": [
                        "Pre-Market",
                        "Most Active",
                        "GE",
                        "LPL",
                        "KEP",
                        "NVS",
                        "ERIC",
                        "SQQQ",
                        "QD",
                        "PKX",
                        "AMD",
                        "MRNS",
                        "QQQ",
                        "TQQQ"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-13",
                "original_text": "The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",
                "features": {
                    "keywords": [
                        "Vivus",
                        "Supply Deal",
                        "Sandoz",
                        "Applied Genetic",
                        "Biogen"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-13",
                "original_text": "Novartis Reports EC Approval Of Xolair Syringe For Self-administration",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EC Approval",
                        "Xolair",
                        "Self-administration"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}